Zobrazeno 1 - 10
of 81
pro vyhledávání: '"Ashish Sarraju"'
Autor:
Sulaiman Somani, Sneha S. Jain, Ashish Sarraju, Alexander T. Sandhu, Tina Hernandez-Boussard, Fatima Rodriguez
Publikováno v:
Communications Medicine, Vol 4, Iss 1, Pp 1-5 (2024)
Abstract Background The prevalence of obesity has been increasing worldwide, with substantial implications for public health. Obesity is independently associated with cardiovascular morbidity and mortality and is estimated to cost the health system o
Externí odkaz:
https://doaj.org/article/adb7381178a446d5a48a6624f3591aaa
Autor:
Akiva Rosenzveig, Joseph Kassab, Lidiya Sul, Dana Angelini, Pulkit Chaudhury, Ashish Sarraju, Leben Tefera
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 21 (2024)
Externí odkaz:
https://doaj.org/article/5ccc3cdccffd4f9f8a84b5bc67eb544e
Autor:
Ashish Sarraju, MD
Publikováno v:
American Journal of Preventive Cardiology, Vol 19, Iss , Pp 100806- (2024)
Therapeutic Area: Other: Artificial intelligence; Misinformation Background: Misinformation regarding CVD prevention is prevalent on the internet and on social media. Chat-based artificial intelligence (AI) models such as ChatGPT have gained over 100
Externí odkaz:
https://doaj.org/article/1897e254a894425c88ab0f2bb4c54049
Publikováno v:
Journal of Medical Internet Research, Vol 26, p e55388 (2024)
In this cross-sectional study, we evaluated the completeness, readability, and syntactic complexity of cardiovascular disease prevention information produced by GPT-4 in response to 4 kinds of prompts.
Externí odkaz:
https://doaj.org/article/119d82da1f25437b96b57836672cb08b
Publikováno v:
American Journal of Preventive Cardiology, Vol 17, Iss , Pp 100647- (2024)
Objective: There remain disparities by race and ethnicity in atherosclerotic cardiovascular disease (ASCVD). Statins reduce low-density lipoprotein cholesterol (LDL-c) and improve ASCVD outcomes. ASCVD treatment patterns across disaggregated race and
Externí odkaz:
https://doaj.org/article/17832882cefa4497a0eb0624bb405b92
Autor:
Mario Funes Hernandez, Meghedi Babakhanian, Tania P. Chen, Ashish Sarraju, Clark Seninger, Vishnu Ravi, Zahra Azizi, James Tooley, Tara I. Chang, Ying Lu, N. Lance Downing, Fatima Rodriguez, Ron C. Li, Alexander T. Sandhu, Mintu Turakhia, Vivek Bhalla, Paul J. Wang
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 13, Iss 2 (2024)
Background High blood pressure affects approximately 116 million adults in the United States. It is the leading risk factor for death and disability across the world. Unfortunately, over the past decade, hypertension control rates have decreased acro
Externí odkaz:
https://doaj.org/article/36e4112308be42eea42c6d787ab0f71d
Autor:
Summer Ngo, Roshini Asirvatham, Grayson L. Baird, Ashish Sarraju, David J. Maron, Fatima Rodriguez
Publikováno v:
American Journal of Preventive Cardiology, Vol 16, Iss , Pp 100594- (2023)
Objective: Statins are the cornerstone for the prevention and treatment of cardiovascular disease. Patients often consult online patient education materials (OPEMs) to inform medical decision-making. We therefore aimed to assess the readability and r
Externí odkaz:
https://doaj.org/article/8392f903aa8942a49194fe6685cfc08c
Autor:
Joseph Kassab, Vishwum Kapadia, Christopher Massad, Ashish Sarraju, Jay Ramchand, Samir R. Kapadia, Serge C. Harb
Publikováno v:
Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease, Vol 12, Iss 22 (2023)
Externí odkaz:
https://doaj.org/article/8f7c6d9b429541c2864834114f87a260
Autor:
Ramzi Dudum, MD MPH, Qiwen Huang, MS, Xiaowei(Sherry) Yan, PhD, Powell Jose, MD, Sumeet Singh Brar, MD, Ashish Sarraju, MD, Fatima Rodriguez, MD MPH
Publikováno v:
American Journal of Preventive Cardiology, Vol 15, Iss , Pp 100569- (2023)
Therapeutic Area: ASCVD/CVD Risk Factors Background: Lipoprotein(a) [Lp(a)] is a causal risk factor for atherosclerotic cardiovascular disease (ASCVD). Despite practice guidelines recommending routine Lp(a) testing, uptake of screening has been low a
Externí odkaz:
https://doaj.org/article/3ef248efe2bc40a08838eaffbb44964a
Autor:
Celeste Witting, Zahra Azizi, Sofia Elena Gomez, Alban Zammit, Ashish Sarraju, Summer Ngo, Tina Hernandez-Boussard, Fatima Rodriguez
Publikováno v:
American Journal of Preventive Cardiology, Vol 14, Iss , Pp 100496- (2023)
Background: Statins are the cornerstone of treatment of patients with atherosclerotic cardiovascular disease (ASCVD). Despite this, multiple studies have shown that women with ASCVD are less likely to be prescribed statins than men. The objective of
Externí odkaz:
https://doaj.org/article/2fd435e87333436293c2375d42b6d5b4